Five China tablet press makers spotlighted as pharma rules tighten

Five China-based tablet press and pharmaceutical machinery makers are positioned in 2026 to serve a market that is demanding faster output, flexible dosage formats and stronger compliance support. The shift matters as regulators in Europe and the U.S. put more weight on technical documentation, computerized controls and machine safety.

Why it matters: - China’s tablet press sector is competing on more than compression speed. Buyers are increasingly weighing documentation, digital controls, tooling compatibility and international conformity. - Pharmaceutical manufacturers need equipment that can support efficient solid-dosage production while fitting regulated quality systems. - Regulation (EU) 2023/1230 will apply from January 20, 2027, adding pressure on machine safety, technical files and conformity assessment for suppliers selling into Europe. - U.S. FDA 21 CFR Part 11 and EU GMP Annex 11 are also pushing tablet press makers toward better electronic records, audit trails and computerized-system functions.

What happened: - A review of China’s tablet press market in 2026 highlighted five China-based companies active in tablet press and pharmaceutical machinery manufacturing. - The companies named were Shanghai Tablet Press Mechanical Components Co., Ltd. (TPCF), Shanghai Tianhe Pharmaceutical Machinery Co., Ltd., Liaocheng Taihe Pharmaceutical Equipment Co., Ltd., Changzhou Chenguang Machinery Co., Ltd. and Shanghai Tianfeng Pharmaceutical Equipment Co., Ltd. - The article framed these companies as examples of different parts of China’s pharmaceutical equipment base, from rotary tablet presses and tooling to broader machinery solutions. - The global tablet press machines market was estimated at about $1.52 billion in 2025 by Global Market Insights. - Fette Compacting was identified as the largest single market participant with more than 9% share.

The details: - TPCF is based in Shanghai and specializes in tablet press machines, tablet press punches and dies, and capsule filling equipment. - The company traces its history to Shanghai Tianma Pharmaceutical Machinery Parts Factory, established in 1978, and Shanghai Tianfan Pharmaceutical Machinery Factory in 2002. - TPCF was registered in 2009 and moved into its current facility in 2015. - The company says its facility is at No. 159 Zhujiabang Road, Xiaokunshan Town, Songjiang District, Shanghai. - TPCF reports a building area of about 15,000 square meters, around 260 employees and an R&D team of 15 engineers. - The company says it operates more than 200 CNC machine tools, including engraving machines, coordinate measuring machines and coordinate grinders. - TPCF reports annual production capacity of about 1,500 sets and monthly delivery of around 80 to 120 tablet presses and capsule filling machines. - About 50% of TPCF sales are reported to come from overseas markets, including Asia, South Africa, the Middle East, the European Union, Russia, and North and West Africa. - The GZPK1060 high-speed rotary tablet press series is available with 76, 95, 113 or 122 stations. - The GZPK1060 series is specified with maximum main and pre-compression forces of 100 kN and a stated single-layer output of about 342,000 to 658,800 tablets per hour, depending on configuration. - Triple-layer configurations for the GZPK1060 are listed at about 114,000 to 219,600 tablets per hour. - The GZPK720 series includes 51 to 99 stations and a stated output range of about 306,000 to 712,800 tablets per hour. - The GZPK620i is described as an intelligent double-outlet high-speed rotary tablet press with optional bilayer capability and a stated output range of about 378,000 to 624,000 tablets per hour. - The single-outlet GZPK280 series comes in 20-, 24- and 30-station configurations with a stated output range of about 96,000 to 198,000 tablets per hour. - The ZPT168 compact rotary tablet press has five, seven, ten or twelve stations, a maximum main compression force of 50 kN, a 220 V single-phase power supply and a net weight of 320 kg. - The ZPTX226-8 R&D rotary tablet press has pre-compression of 16 kN and main compression of 80 kN. - The ZPTX420-17G is a 17-station bilayer tablet press with a maximum main compression force of 150 kN and pre-compression force of 100 kN. - TPCF specifies a typical tablet size of 36.5 × 26.5 × 13 mm for the ZPTX420-17G, tablet thickness of 9 to 14 mm and maximum filling depth of about 32 to 33 mm. - The ZPT680C is designed for triple-layer composite tablets and has a maximum combined main compression force of 150 kN across the three layers. - TPCF’s LG-series roller compactors are designed for dry granulation and produce finished particle sizes of 10 to 80 mesh. - The LG100 has a capacity of about 1.5 to 15 kg per hour, while the LGS500 handles about 1,500 to 3,000 kg per hour. - TPCF also offers the QVC-3 vacuum conveyor, XCJ-1.1 dust collector and CF-1 anti-sticking powder sprayer. - The company manufactures tablet press tooling from technical drawings or physical samples and supports D, B, BB, BBS, ZP and ZPT standards. - TPCF says punches can use S7 or 6CrW2Si materials and dies can use D2 or GCr15. - Optional punch coatings include chrome, CrNi, TiNi and DLC. - Several tablet press models use a one-piece 2Cr13 stainless-steel die table. - TPCF says the 2Cr13 design is intended to reduce delamination risk associated with surface-plated table materials under continuous mechanical friction. - TPCF says its equipment is designed according to GMP-related requirements and that it holds CE and ISO certifications. - Shanghai Tianhe Pharmaceutical Machinery is based in Shanghai and is active in the domestic tablet press manufacturing sector. - The company sits in a city that is a long-established industrial and engineering center. - Liaocheng Taihe Pharmaceutical Equipment is based in Liaocheng, Shandong Province, and is part of China’s wider pharmaceutical equipment manufacturing network. - The company reflects a regional manufacturing base beyond China’s major coastal industrial centers. - Changzhou Chenguang Machinery is based in Changzhou, Jiangsu Province, another major manufacturing center in eastern China. - Shanghai Tianfeng Pharmaceutical Equipment is another Shanghai-based company active in pharmaceutical equipment manufacturing.

Between the lines: - The market is moving from a focus on raw machine output toward a broader package of machine performance, traceability and regulatory readiness. - The companies that can combine mechanical precision with digital documentation and compliance support may be better positioned for exports and regulated customers. - The emphasis on bilayer and triple-layer presses shows that drug makers want more flexibility in tablet design and release profiles. - The repeated focus on tooling materials and surface treatments suggests that tablet quality and uptime remain central competitive issues.

What's next: - Suppliers selling into Europe will need to align with the January 2027 application of Regulation (EU) 2023/1230. - Tablet press makers are likely to keep adding electronic records, audit trails and computerized controls to meet data-integrity expectations. - Demand should remain centered on high-speed rotary presses, pilot-scale machines, granulation equipment and tooling systems that support multiple product formats. - China’s tablet press manufacturers are likely to be judged increasingly on compliance readiness as much as on mechanical specs.

The bottom line: - China’s tablet press industry is entering 2026 with strong manufacturing depth, but the next competitive edge is compliance, digital control and documentation as much as speed and force.